High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors
Condition(s):Solid Tumors; Brain TumorsLast Updated:January 25, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Solid Tumors; Brain TumorsLast Updated:January 25, 2022Terminated
Condition(s):Rectal CancerLast Updated:August 15, 2013Unknown status
Condition(s):Nasopharyngeal Neoplasms; Salivary Gland Diseases; Bone Marrow Diseases; MucositisLast Updated:July 13, 2017Unknown status
Condition(s):Head and Neck CancerLast Updated:February 1, 2017Completed
Condition(s):CancerLast Updated:June 10, 2008Completed
Condition(s):Myelodysplastic SyndromesLast Updated:October 25, 2018Completed
Condition(s):Prostatic NeoplasmsLast Updated:April 30, 2012Completed
Condition(s):Lymphoma; Hodgkin’s Disease; Non-Hodgkin’s LymphomaLast Updated:November 1, 2009Completed
Condition(s):Breast Cancer; Lung Cancer; Neurotoxicity; Ovarian Cancer; Prostate Cancer; Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:October 17, 2012Completed
Condition(s):Colorectal CancerLast Updated:August 3, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.